Benign prostat hiperplazisi nedeniyle transüretral prostat rezeksiyonu uygulanan hastalarda tedavi etkinliği ile ilişkili parametrelerin araştırılması

Abstract

Aim: Evaluation of the postoperative benefit rates and various parameters that may be associated with the postoperative benefit in patients who underwent transurethral resection of the prostate due to benign prostate enlargement and the treatment efficacy of transurethral resection of the prostate and to investigate whether the parameters that can predict this can be achieved. Materials and Methods: 100 patients who underwent transurethral resection of the prostate in our clinic between 2015-2016 July were evaluated retrospectively. Preoperative estimated prostate weight, international prostate symptom score , maximum flow rate, postvoid residual urine volume , and resected prostate tissue weights were recorded. In the postoperative six weeks to six months, the data of the patients were re-recorded and statistical analyzes were performed.
 Results: It was determined that the decrease in IPSS was 11.40 (53.4%), the increase in Qmax was 11.10 ml/s (110%) and the decrease in PVR was 59.60 ml (59%). The decrease in IPSS was found to be statistically significantly higher in those with preoperative IPSS ≥ 20, preoperative Qmax ≤ 10 ml/sec, and PVR >100 ml (p100 ml (p=0.012, p 50 g and RDA / TPA ≤ 0.3 (p=0.027 and p=0.008, respectively). Conclusion: We think that obtaining clearer data that may be related to the efficacy of transurethral resection of the prostate can guide clinicians in patient follow-up and treatment selection, and more studies are needed on this subject.

Difficulties experienced by patients with benign prostatic hyperplasia regarding their physical symptoms

“…Undoubtedly, the worsening functional impairments and physical symptoms hinder patients from performing their daily activities, negatively affecting their social lives and reducing their quality of life 2,10,11 . Generally, multimodal therapy is applied in treating BPH, including lifestyle changes, pharmacological treatment, and surgical approaches when pharmacological treatments lose their effectiveness 12,13 . However, surgery is the most effective and promising treatment available to control symptoms 14–17 …”

“…2,10,11 Generally, multimodal therapy is applied in treating BPH, including lifestyle changes, pharmacological treatment, and surgical approaches when pharmacological treatments lose their effectiveness. 12,13 However, surgery is the most effective and promising treatment available to control symptoms. [14][15][16][17] It should be noted that providing successful patient care in surgery is only possible through a detailed evaluation of patients.…”